Actively Recruiting

Age: 40Years +
All Genders
NCT04869813

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)

Led by The Cleveland Clinic · Updated on 2026-02-11

70

Participants Needed

1

Research Sites

298 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of the proposed research is to investigate Magnetic Resonance (MR) Fingerprinting and P-MRS (Phosphorus-31 MR Spectroscopy) imaging for characterization of skeletal muscle in heart failure patients with sarcopenia. Heart failure patients with and without sarcopenia will be scanned using MR Fingerprinting and an existing Post-exercise phosphocreatine (PCr) recovery MR imaging protocol to obtain characteristic profiles of quantitative T1, T2, and PCr recovery rate.

CONDITIONS

Official Title

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Heart failure patients aged 40 years or older with stable chronic heart failure and left ventricle ejection fraction 40% or less as determined by cardiac MRI
  • Healthy volunteers aged 40 years or older without diagnosed heart failure or sarcopenia
Not Eligible

You will not qualify if you...

  • Advanced liver disease, advanced cancer, or advanced chronic obstructive pulmonary disease in heart failure patients
  • Advanced liver disease, advanced cancer, or advanced chronic obstructive pulmonary disease in healthy volunteers
  • Contraindications to MRI
  • Presence of heart pacemaker or defibrillator
  • Having electronic or implanted stimulators or devices including deep brain stimulator, vagus nerve stimulator, bladder stimulator, spine stimulator, neurostimulators, or implanted electrodes or wires
  • Having cochlear implant or other ear implants
  • Having implanted drug pumps such as for insulin, narcotic/pain medications, or drugs to treat spasticity
  • Having programmable shunt
  • Presence of aneurysm clips and coils
  • Presence of stents
  • Presence of filters such as blood clot filters
  • Metal fragments in the body or eye such as BBs, bullets, shrapnel, metal pieces, or shavings

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

Loading map...

Research Team

T

Timothy A Engelman, LPN

CONTACT

W

Wilcox D Wilcox, BA

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here